We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLU icon
1226
State Street Utilities Select Sector SPDR ETF
XLU
$23.8B
$2K ﹤0.01%
+40
New +$1.59K
XNCR icon
1227
Xencor
XNCR
$1.44B
$2K ﹤0.01%
222
ZVRA icon
1228
Zevra Therapeutics
ZVRA
$567M
$2K ﹤0.01%
182
AVBP icon
1229
ArriVent BioPharma
AVBP
$1.4B
$2K ﹤0.01%
111
TECX
1230
Tectonic Therapeutic
TECX
$572M
$2K ﹤0.01%
80
ALLO icon
1231
Allogene Therapeutics
ALLO
$580M
$1K ﹤0.01%
535
-30,290
-98% -$40.2K
ALT icon
1232
Altimmune
ALT
$607M
$1K ﹤0.01%
235
AMRN
1233
Amarin Corp
AMRN
$291M
$1K ﹤0.01%
66
-1
-1% -$11
ANNX icon
1234
Annexon
ANNX
$822M
$1K ﹤0.01%
352
ARCT icon
1235
Arcturus Therapeutics
ARCT
$161M
$1K ﹤0.01%
90
ATXS
1236
DELISTED
Astria Therapeutics
ATXS
$1K ﹤0.01%
186
AURA icon
1237
Aura Biosciences
AURA
$727M
$1K ﹤0.01%
165
AUTL
1238
Autolus Therapeutics
AUTL
$386M
$1K ﹤0.01%
575
-22,352
-97% -$37K
AVIR icon
1239
Atea Pharmaceuticals
AVIR
$391M
$1K ﹤0.01%
242
BCYC
1240
Bicycle Therapeutics
BCYC
$274M
$1K ﹤0.01%
103
CDXS icon
1241
Codexis
CDXS
$137M
$1K ﹤0.01%
269
CMPS
1242
Compass Pathways
CMPS
$1.46B
$1K ﹤0.01%
+327
New +$1.23K
CRGX
1243
DELISTED
CARGO Therapeutics
CRGX
$1K ﹤0.01%
152
DSGN icon
1244
Design Therapeutics
DSGN
$744M
$1K ﹤0.01%
350
EDIT icon
1245
Editas Medicine
EDIT
$394M
$1K ﹤0.01%
277
ERAS icon
1246
Erasca
ERAS
$6.48B
$1K ﹤0.01%
1,074
ESPR
1247
DELISTED
Esperion Therapeutics
ESPR
$1K ﹤0.01%
650
EYPT icon
1248
EyePoint Inc
EYPT
$1.01B
$1K ﹤0.01%
144
FDMT icon
1249
4D Molecular Therapeutics
FDMT
$528M
$1K ﹤0.01%
184
-9,394
-98% -$33K
LKFT
1250
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.87B
$1K ﹤0.01%
51

Similar funds

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.